Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection

Background: Heart transplantation remains the gold standard for end-stage heart failure, with current ex vivo organ storage times limited to 4 to 6 h before critical tissue damage occurs. Many preservation solutions exist in an attempt to limit both ischemic and reperfusion damage. In order to compa...

Full description

Bibliographic Details
Main Authors: Ferng, Alice S., Schipper, David, Connell, Alana M., Marsh, Katherine M., Knapp, Shannon, Khalpey, Zain
Other Authors: Univ Arizona, Coll Med, Dept Surg, Div Cardiothorac Surg
Language:en
Published: BIOMED CENTRAL LTD 2017
Subjects:
Online Access:http://hdl.handle.net/10150/622950
http://arizona.openrepository.com/arizona/handle/10150/622950
id ndltd-arizona.edu-oai-arizona.openrepository.com-10150-622950
record_format oai_dc
spelling ndltd-arizona.edu-oai-arizona.openrepository.com-10150-6229502017-04-01T03:00:38Z Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection Ferng, Alice S. Schipper, David Connell, Alana M. Marsh, Katherine M. Knapp, Shannon Khalpey, Zain Univ Arizona, Coll Med, Dept Surg, Div Cardiothorac Surg Univ Arizona, Coll Med, Dept Physiol Sci Univ Arizona, Coll Med, Dept Biomed Engn Univ Arizona, Coll Med Univ Arizona, Coll Med, BIOS Inst, Stat Consulting Lab Organ preservation solution Cardiac myoblasts Mitochondria Bioenergetics Somah Celsior Perfadex Background: Heart transplantation remains the gold standard for end-stage heart failure, with current ex vivo organ storage times limited to 4 to 6 h before critical tissue damage occurs. Many preservation solutions exist in an attempt to limit both ischemic and reperfusion damage. In order to compare the effects of various storage solutions, mitochondrial function can be used to provide a sensitive analysis of cellular metabolic function. Methods: Experimental plates were seeded with cardiac myoblasts and kept in suspended animation for either 4 or 8 h at either 4(o) or 21 degrees C, in Celsior (R), Perfadex (R), or Somah storage solutions. Cells were then reanimated for 1 h at 37 degrees C to simulate a reperfusion or clinical transplant scenario. Cellular bioenergetics were measured immediately thereafter to examine biochemical differences between preservation solutions and their effectiveness on preserving metabolic function. Results: The oxygen consumption rates of Somah solution were significantly higher than Celsior (R) and Perfadex (R) at 4 degrees C, with the exception of Perfadex (R) at 4(o) for 4 h. This effect was sustained up to 8 h. At 21 degrees C, oxygen consumption rates of Somah solution are significantly higher than Celsior (R) and Perfadex (R) at basal conditions after 4 h, but this effect is not sustained after 8 h. Conclusions: The purpose of this experiment was to study the efficacy of various preservation solutions on a mitochondrial level. The significantly higher oxygen consumption rates of Somah at 4 degrees C suggests that Somah solution may have the ability to protect cellular mitochondrial integrity, improve transplanted organ function by reducing ischemic-reperfusion injury, and thereby improve transplant outcomes. Given that Somah offers benefits over Celsior (R) and Perfadex (R) at 4 degrees C, it should be a target in future organ preservation solution research. 2017-01-26 Article Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection 2017, 12 (1) Journal of Cardiothoracic Surgery 1749-8090 28126002 10.1186/s13019-017-0564-x http://hdl.handle.net/10150/622950 http://arizona.openrepository.com/arizona/handle/10150/622950 Journal of Cardiothoracic Surgery en http://cardiothoracicsurgery.biomedcentral.com/articles/10.1186/s13019-017-0564-x © The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 BIOMED CENTRAL LTD
collection NDLTD
language en
sources NDLTD
topic Organ preservation solution
Cardiac myoblasts
Mitochondria
Bioenergetics
Somah
Celsior
Perfadex
spellingShingle Organ preservation solution
Cardiac myoblasts
Mitochondria
Bioenergetics
Somah
Celsior
Perfadex
Ferng, Alice S.
Schipper, David
Connell, Alana M.
Marsh, Katherine M.
Knapp, Shannon
Khalpey, Zain
Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection
description Background: Heart transplantation remains the gold standard for end-stage heart failure, with current ex vivo organ storage times limited to 4 to 6 h before critical tissue damage occurs. Many preservation solutions exist in an attempt to limit both ischemic and reperfusion damage. In order to compare the effects of various storage solutions, mitochondrial function can be used to provide a sensitive analysis of cellular metabolic function. Methods: Experimental plates were seeded with cardiac myoblasts and kept in suspended animation for either 4 or 8 h at either 4(o) or 21 degrees C, in Celsior (R), Perfadex (R), or Somah storage solutions. Cells were then reanimated for 1 h at 37 degrees C to simulate a reperfusion or clinical transplant scenario. Cellular bioenergetics were measured immediately thereafter to examine biochemical differences between preservation solutions and their effectiveness on preserving metabolic function. Results: The oxygen consumption rates of Somah solution were significantly higher than Celsior (R) and Perfadex (R) at 4 degrees C, with the exception of Perfadex (R) at 4(o) for 4 h. This effect was sustained up to 8 h. At 21 degrees C, oxygen consumption rates of Somah solution are significantly higher than Celsior (R) and Perfadex (R) at basal conditions after 4 h, but this effect is not sustained after 8 h. Conclusions: The purpose of this experiment was to study the efficacy of various preservation solutions on a mitochondrial level. The significantly higher oxygen consumption rates of Somah at 4 degrees C suggests that Somah solution may have the ability to protect cellular mitochondrial integrity, improve transplanted organ function by reducing ischemic-reperfusion injury, and thereby improve transplant outcomes. Given that Somah offers benefits over Celsior (R) and Perfadex (R) at 4 degrees C, it should be a target in future organ preservation solution research.
author2 Univ Arizona, Coll Med, Dept Surg, Div Cardiothorac Surg
author_facet Univ Arizona, Coll Med, Dept Surg, Div Cardiothorac Surg
Ferng, Alice S.
Schipper, David
Connell, Alana M.
Marsh, Katherine M.
Knapp, Shannon
Khalpey, Zain
author Ferng, Alice S.
Schipper, David
Connell, Alana M.
Marsh, Katherine M.
Knapp, Shannon
Khalpey, Zain
author_sort Ferng, Alice S.
title Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection
title_short Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection
title_full Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection
title_fullStr Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection
title_full_unstemmed Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection
title_sort novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection
publisher BIOMED CENTRAL LTD
publishDate 2017
url http://hdl.handle.net/10150/622950
http://arizona.openrepository.com/arizona/handle/10150/622950
work_keys_str_mv AT ferngalices novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection
AT schipperdavid novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection
AT connellalanam novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection
AT marshkatherinem novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection
AT knappshannon novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection
AT khalpeyzain novelvsclinicalorganpreservationsolutionsimprovedcardiacmitochondrialprotection
_version_ 1718436034860023808